Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Me
Go back to Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Me| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 225.01 -0.91 (0.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.92 | 52 Week High | $160.00 | |||
| Open | $225.27 | 52 Week Low | $95.80 | |||
| Day High | $226.19 | P/E | 41.82 | |||
| Day Low | $222.93 | EPS | $5.38 | |||
| Volume | 63,624 | |||||
